Yves Bikorimana: What Every Lab and Clinician Should Know on Pseudothrombocytopenia
Yves Bikorimana, CEO at MedData-Rwanda and Lab Scientist at The University Teaching Hospital of Kigali-Chuk, shared a post on LinkedIn.
“Pseudothrombocytopenia (PTCP): What Every Lab and Clinician Should Know
Pseudothrombocytopenia is a laboratory artifact where platelet counts appear falsely low on automated analyzers, despite the patient having a normal platelet count in vivo. Importantly, it is not a true clinical thrombocytopenia and does not increase bleeding risk.
Why does it happen?
The most common cause is EDTA-dependent platelet clumping. In some individuals, EDTA (the anticoagulant used in routine CBC tubes) exposes platelet surface antigens, leading to antibody-mediated platelet aggregation. Automated analyzers then misinterpret these clumps as leukocytes or exclude them entirely, resulting in a falsely low platelet count.
Key Laboratory Features
- Low platelet count on automated CBC
- Platelet clumps visible on peripheral blood smear
- Normal platelet count when blood is collected in:
- Sodium citrate
- Heparin
- Magnesium sulfate (rarely used but effective)
Clinical Significance
- Patients are usually asymptomatic
- No bleeding manifestations
- Can be mistaken for serious conditions like:
- Immune thrombocytopenic purpura (ITP)
- Bone marrow disorders
- Drug-induced thrombocytopenia
Why recognition matters
Failure to identify PTCP can lead to:
- Unnecessary platelet transfusions
- Inappropriate treatments (e.g., steroids, IVIG)
- Delays in surgeries or invasive procedures
- Patient anxiety and misdiagnosis
Best Practice Approach
- Always review the peripheral smear when thrombocytopenia is detected
- Repeat platelet count using an alternative anticoagulant
- Correlate laboratory findings with clinical presentation
Take-home message
Pseudothrombocytopenia highlights the importance of laboratory-clinical correlation and the continued value of manual smear examination in modern diagnostics.”
Find the latest updates on Hemostasis Today.
-
May 29, 2026, 17:23Rita Schwab: Current Clinical Management of Trauma without the Use of Allogenic Blood Products
-
May 29, 2026, 17:22Brian Schiro: Excited to Provide Guideline Based Care at the Aortic Center
-
May 29, 2026, 17:20Martin Widschwendter: How Molecular Detection Tests Could Transform Endometrial Cancer Care
-
May 29, 2026, 17:18Nina Lansbury: Supporting a Period Friendly World With Menstrual Health Research and Education
-
May 29, 2026, 17:16Ipsita Chatterjee: Red is Not Shame, Red is Power, Red is a Woman
-
May 29, 2026, 16:49Abdulrahman Nasiri: The Evolving Role of Romiplostim in SAA
-
May 29, 2026, 16:46Soumen Bhattacharya: UC-II and Immune Modulation in Osteoarthritis
-
May 29, 2026, 16:38Ana Pedrero Gil: Red Blood Cell Transfusion Practice in Spain – High Inappropriateness Despite Low Overall Use
-
May 29, 2026, 15:40Lena Volland: Expanding Holistic Care in Bleeding Disorders Through Pelvic Health Physical Therapy at WFH Congress